Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New Q4 investor presentation on ALRT's website, I think it was posted this morning, I didn't see it early this week: https://www.alrt.com/documents/ALRT%20Web%20Deck%202023-Q4.pdf
Wow. Share price of $0.0261 and 0 shares traded today. This ticker is on fire!
Thanks, John!
Looks very much improved...
glta!
www.GluCurve.ca is live, I believe it previously said coming soon.
if you haven't read it scroll down to my post #12982 for an update.
i'll be reaching out to them again soon. re-reading ir's response something caught my eye... will update as available.
285,000 shares traded today. Seems like a high number. Anything going on?
I just want to make a 1/4 million dollars on ALRT so I can make up for the 1/4 million I lost in my long-term investments with Biden as President 😂 GLTA!
ALRT news: Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study
SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCQB: ALRTF), a diabetes management company, announces the patent application titled Method and System of Monitoring a Diabetes Treatment Plan ("Predictive A1c") has been granted in Singapore and has received notice of allowance in the United States.
Predictive A1c is the Company's cornerstone, the first of its kind U.S Food & Drug Administration ("FDA") cleared Diabetes Management Solution that shifts patient self-management to active patient management while providing best practice guidelines and ensuring adherence to care plans. Predictive A1c is owned by Sidney Chan, Chairman and CEO of ALRT. The Company has the right to utilize Predictive A1c pursuant to an informal license with Mr. Chan and expects to acquire the intellectual property in the next 12 months. Final steps have been taken in the United States Patent and Trademark Office for issuance of the US patent for Predictive A1c, and the US patent is expected to grant in the coming weeks. The Company expects Predictive A1c patent applications submitted in other jurisdictions to advance to grant in 2024.
Additionally, ALRT announces the successful completion of its 24-week study led by Singapore General Hospital ("SGH"). A total of 25 insulin-treated patients with type 2 diabetes mellitus were enrolled into the ALRT Diabetes Solution platform. The patients performed twice daily capillary blood glucose checks and weekly glucometer uploads. The platform then provided insulin dose suggestions and alerts to the physicians. All patients experienced a mean drop of 1.2 percent in glycated hemoglobin (HbA1c). The findings from the study validated the significant value that ALRT Diabetes Solution may potentially bring to patients and health care providers. The results were presented at the recent International Diabetes Federation Western Pacific Congress 2023 in Kyoto, Japan, and are expected to be published in the future.
"We are pleased to see the continued success of the ALRT Diabetes Solution from the outcome of this SGH study that replicated the results of our previous clinical trials in Canada and Kansas City, all of which have resulted in a 1.2 percent drop in mean A1c," commented Sidney Chan, Chairman and CEO of ALRT. "The successful conclusion of this study gives ALRT the clinical evidence needed to continue forwarding our efforts in deploying ALRT Diabetes Solution in ASEAN territories. On top of that, receiving the patent grant for Predictive A1c protects our clinically proven effective diabetes management system against would be competitors while securing our competitive advantage over other software platforms."
About ALR Technologies SG Ltd.
ALRT is a data management company that developed the ALRT Diabetes Solution, a comprehensive approach to diabetes care that includes an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA- cleared Insulin Dosing Adjustment program. The overall goal is to optimize diabetes drug therapies to drive improved patient outcomes.
In addition, the animal health division of ALRT has developed the GluCurve Pet CGM; a solution to assist veterinarians better determine the efficacy of insulin treatments and to help to identify the appropriate
dose and frequency of administration for companion animals, thereby delivering the same optimization of diabetic drug therapies to pets as to humans.
More information about ALRT and the GluCurve Pet CGM can be found at www.alrt.com and https://www.glucurve.com/Index.
ALRT share price movement: zzzzzzzzzzzzzzzzzzzzzzzzz
I can smell what The Rock is cooking!
Why Your Pet Might Need a Glucose Monitor via Popular Science
"One diabetes management company, ALR Technologies, is developing a CGM specifically for cats and dogs. It decided to expand into the animal health space after noticing a lack of tools for veterinarians. “They’re just in such a need for a better way to check blood sugar,” says Joe Stern, who heads ALR’s animal health division.
The device, called GluCurve, uses a pet-friendly adhesive and applicator. Its software, which includes a specialized dose calculator for insulin treatment, is designed to share data across a veterinary practice. GluCurve was soft-launched in January and is now off the market while the company modifies the hardware design. It plans to begin selling the product again in the next few months, according to Stern. "
https://www.popsci.com/health/glucose-monitor-pets/
Yep, got most of them, thanks. And big props to jammaster for the update.
Thanks for the update, seems encouraging. Will give an update if I make it to the 2024 VMX conference in orlando
Hope you got 'em BuzzLite.
Thanks for the update Jammastermike. GLTA
Put a buy in for 25k at the ask. Fingers crossed.
Hi guys, as follows is my email sent to Joe @ Animal Health @ ALRT... I'd like to point out I sent this email yesterday (Sunday) evening and had Joe's response waiting for me Monday morning.
Gentlemen,
Thank you for endeavoring to bring the Glu-Curve to market.
I'm checking in on progress re: the Canadian Glu-Curve launch.
The Canadian Glu-Curve web-site (see attached) is not very promising as it states the Glu-Curves are "coming soon" which looks outdated and as if there may be problems.
It is the middle of September. In your most recent PR you've stated shipments will be August through October. That puts us halfway through your stated delivery window.
To date how many units have shipped to retailers, veternarians, etc. Based on the last six weeks what are your sales and acct. placement projections through October?
I'd appreciate an update on progress, please.
My best regards,
Mike
Joe's Response:
Hi Mike,
Unfortunately we cannot go into specifics privately because we are publicly traded company, but after issuing the August 7th news release there were some last minute changes in manufacturing and delivery. These were not bad changes or problems, they were rather beneficial for our company, customers, and shareholders, but it has caused a slight delay and we are now scheduled for delivery in October. We will be exhibiting at VET (https://www.veterinaryeducationtoday.ca/Toronto/) in Canada at the end of October and then plan to have a separate booth from Covetrus at VMX in January and WVC in February to help with the crowd control and assist in the relaunch in the US. With that being said, we made some strategic changes to ensure proper inventory and that the best possible product could be ready for the conferences since we sold out in hours during VMX for the soft launch earlier this year.
Thanks for interest and patience as a shareholder, we will be releasing a lot more information and news in the coming weeks/months as we execute on our plan. But please don’t be discouraged by the minor delays we have experiences, we are in a better position now then we have ever been, it has just taken a bit longer then anticipated.
Joe Stern
Head of Animal Health
Joe.Stern@alrt.com
I just hit the Ask at 2.7¢/share for another 30K shares. I figure WTF. If I'm gonna be a bag holder, I might as well go out in style. Not sure where this company is going, or when.
Hi guys,
I just sent an email to ALRT investor relations.
Asking for an update.
Will advise as available.
glta!
I bought my first stock in the 70's in a company called Tennant Company, recommended to me by my father who was using Baird as an investment broker. They did well for me. I never fooled around with Penny stocks until around 2015, when I started day-trading hemp stocks. Did ok until that bubble burst, but I did pick up on ALRT somewhere around 2016-2017. I forget exactly when. Got out of other Pennies and day-trading altogether, and only swing trade now. Lost my arse on ABWN when the management went the toxic dilution route. It was trading in the $3 range and I went to Europe for while, and took my eye off of them and all my stocks. When I got back, ABWN share price had gone trips and lost it all. That's when I decided I was done with pennies other than ALRT for the exact reason you stated - that it appeared Mr. Chan was the real deal, the product looked promising, and he had a lot of his own money invested in his company.
I would have exited a while ago when share price got into the .06 - .07¢ range (in at around 0.035¢), but trading so thinly it made no sense to try to sell with no volume traded. Would have had to drop my drawers to unload. Like many who have been hanging onto ALRT for these years and longer, fingers crossed that they start seeing a good revenue stream sooner than later, and peeps get interested in this company. If it went to a dime or R/S to uplist and then share price grew from there, I'd be ecstatic. An R/S putting them on the big boards would bring more notice, but as you know... R/Ss don't always work out for the better. I guess we'll see!
GLTU!
thank you lastone :)
i highly enjoy, and value, reading your perspective.
we've got first mover advantage which is great... now is the time to cement relationships with the reps.
lastone, i hope i speak for the group in saying, 'thanks! you're a real gent!'
good luck sir.
i was new to the market 10 yrs. ago and fell in love with this company. my sentiment around chan has always been very favorable. the glu-curve is a strong idea with fabulous potential, and something is telliing me we may be in for a suprise.
I truly appreciate Mr. Chan's efforts and avoidance of toxic dilution of shares, having been burned badly by dilution in the past with another penny. So far, so good.
Keeping the faith, having picked up another 25K shares recently at 3¢, but exiting at this point would be silly and costly. Anticipation of a "huge" return has gone by the wayside some time ago. Just looking for a "fair" return, hopefully sooner than later. GLTA
Also, the shreprice is a mirage as we see today. one 50k buy at .03 and the ask is now .0399 with only 29k there. Any real buying will move the price up significantly and quickly. It's a low volume stock so large swings are to be expected and don't reflect real value in my opinion
My assessment has 3 categories, the product, company, and stock.
The Product:
I think the GluCurve Pet CGM is quite ingenious, I have talked to multiple veterinarians and diabetic pet owners and they all say the same thing. A pet CGM is desperately needed because you cant check sugar levels on cats or dogs using a lancet, meter, and test strips. Without a CGM its a guessing game, that's why using human CGMs off label from a pharmacy has become so popular. ALRT is capitalizing on a unique opportunity because they already have a diabetes platform in place for humans, they just had to modify it for animals. By doing so they solve all the problems of using a human CGM because they offer animal specific software to vets and pet owners, sell directly to vets, and support the product. Human CGMs have human software for human patient use, have to be prescribed by a pharmacy, and offer no support for animal use. ALRT is literally selling a one of a kind product to a market that desperately wants it with no real competition.
The Company:
I have incredible respect for the CEO Sidney Chan (the company), most CEOs go public on the OTC markets to sell toxic dilution and rip off shareholders... But Sidney has funded the company himself to the tune of over $20,000,000. I don't think people appreciate that he could have let the company go bankrupt at any time and gone private but he didn't. He could of also sold toxic dilution to pay for expenses but he didn't do that either. Instead he has funded the company himself and through his or his family's trust and backed it up with options to buy common shares as high as .05 each if I remember correctly. That means for him to win, we all have to win.
The Stock:
Because all of us have been invested in ALRT for years I think we have a jaded view where many feel like they are owed a huge return and have lost patience with the stock so the delays this year have killed the excitement. But reading the past 3 PRs from December, June, and August makes me extremely excited. Every PR the sales value of the order goes up, they are launching in Canada direct to clinics at higher margins, and they are relaunching in the US and EU through Covetrus shortly after. They have a better CGM, better manufacturer, and obviously huge demand. Clearly they have had manufacturing issues that have caused delays, but that is outside of their control so I don't blame ALRT for that and it doesn't change my excitement or long term view. When all sorted, the GluCurve seems like a cash cow and the stock price will reflect that in time regardless of current price. In my opinion, the current price is a huge buying opportunity right before they achieve success. I'm not worried about day to day price because if it triples tomorrow I would not sell a share. I'm looking long term for life changing returns not short term for a double up.
I am as bullish on ALRT as I have ever been and I am more confident in the company then ever because I see progress and perseverance and it comes at the CEOs expense not us shareholders. I have no doubt the shareprice will be significantly higher soon so weather that takes a few weeks or a few months I'm not worried about it.
nothing much, wrapping up a fantastic summer.
crazy, effin world right now... traveling.
i hope your operation is doing well and all is great.
best,
mike
What's up Mikey? Glad to see you posting. Gltu....
good evening, group. glta!
lastonesitting... hi :)
would very much appreciate your assessment of our current affairs, and perhaps any forward thinking riffs?
if no, no problem :)
thanks, best regards & glty!
mike
Yes. I know. It would not have been possible to buy that many shares now, on the ask.
It has been mentioned that more news is coming. Hopefully we keep getting pr,s that result in some buying and movement on share price.
I am all for a reverse split and uplisting, but not where we are at now.
Last time I looked, buying on the ASK drives up the ASK price. Which it did when I bought that last 25K lot. But I'll by those nickel shares off of you for 2¢ a share, johnglenn, Right now!!!!!!
I bought a bunch on the 5 cent offering. Could have waited and bought at.03 and .04. Minute I sell....this thing goes to the moon.
Because you bought more mcvee. Duh. For the love of God will you please sell now, right now!!!!
Share price is moving in the wrong direction. Starting to really wonder about this company and stock. Seems to be no interest out there.
Didn’t realize there were so many players in the market. Still, I’ll continue to average down my losses by purchasing more shares at $0.03 and the hope of selling some shares when it hits $12.50/share.
COMPETITION ANALYSIS
Competitive analysis and profiles of the major players in the pet diabetes care devices, such as AccuBioTech Co., Ltd., Allison Medical Inc., ALR Technologies Inc., Becton, Dickinson and Company, MED Trust, Merck Animal Health, TaiDoc, UltiMed, Inc., Zoetis, i-SENS, Inc. are provided in this report. There are some important players in the market such as AccuBioTech Co., Ltd., Allison Medical Inc., ALR Technologies Inc., Becton, Dickinson and Company. Various players have adopted strategies like partnership, and acquisition as key developmental strategies to improve the product portfolio of the pet diabetes care devices market.
Partnership in the market
In June 2022, ALRT, the diabetes management company, announced the completion of a definitive manufacturing agreement with Infinovo Medical Co. Ltd. to manufacture and supply the Continuous Glucose Monitor (“CGM”) hardware that is utilized as a part of the ALRT GluCurve Pet CGM. This agreement gives ALRT the exclusive global rights to distribute the Infinovo CGM hardware for the animal health market, providing long-term production and supply.
In December 2022, ALRT, the diabetes management company, announced its co-branded distribution agreement with Covetrus, Inc., a global leader in animal-health technology and services, for ALRT's GluCurve Pet CGM, a continuous glucose monitoring (“CGM”) system for diabetic cats and dogs.
Picked up another 25K shares of this POS stock at the ask of 3¢. Why? IDK. But I swear to God - this is it. No more. Supposedly their Canada sale happened yesterday. We'll see. Got that sinking feeling that I'm just another bag holder, but hope eternal. GLTUA
That's why we need this ticker to skyrocket! Before Bidenflation gets much worse
Picked up some groceries to make cheesesteaks at lunch. $49.00! $10 for 12oz of shaved ribeye. Can’t even make it an even pound, for crying out loud. And the gov says the economy is booming. Yeah, right! Just not for the little guy.
Glucurve.ca is up and running
Clicked on pre order and it says sold out. The cost is $149.99 CAD
Come on gang at .02 per share we can get a million shares and be a real player for only 20 grand
LOL. That comment brought a smile to my face! I see that you're in love with Bidenomics just like me!
At $16.00/share I’ll sell half my bag. Otherwise this becomes part of my estate and the wife would dump it for a free bag of groceries. In the current economics, that’s not far off its true value.
Optimistic, I see! GLTUA
i have a sell order in for 25% of my bag @ $.50
glta
I'd exit at 7 or 8¢ a share if the volume is there. Not getting my hopes up, though. Been hearing "dollar-land" for years now, and 6 or 7¢ is like a brick wall. Been hanging in the 3 to 4¢ range for years. Many reasons for that, but regardless, it's been far too long without positive price movement. Patience is a virtue I guess. GLTUA
I have only been waiting since the late 80's for the excitement to begin. Well it gives me something to hope for . Was hoping for a buck a share now a nickel looks good. good luck to us all
Glad you found it helpful. 23+ years and still patiently waiting.
Followers
|
148
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
13380
|
Created
|
10/05/09
|
Type
|
Free
|
Moderators |
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |